Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-7-23
pubmed:abstractText
People with neurofibromatosis 1 (NF1) have multiple benign neurofibromas and a 10% lifetime risk of developing malignant peripheral nerve sheath tumors (MPNSTs). Most MPNSTs develop from benign plexiform neurofibromas, so the burden of benign tumors may be a risk factor for developing MPNST. We studied 13 NF1 patients with MPNSTs and 26 age- and sex-matched controls (NF1 patients who did not have MPNSTs) with detailed clinical examinations and whole-body MRI to characterize their body burden of internal benign neurofibromas. Internal plexiform neurofibromas were identified in 22 (56%) of the 39 NF1 patients studied. All six of the NF1 patients with MPNSTs under 30 years of age had neurofibromas visualized on whole-body MRI, compared to only 3 of 11 matched NF1 controls under age 30 (p < 0.05). Both the median number of plexiform neurofibromas (p < 0.05) and the median neurofibroma volume (p < 0.01) on whole-body MRI were significantly greater among MPNST patients younger than 30 years of age than among controls. No significant differences in whole-body MRI findings were observed between NF1 patients with MPNSTs and controls who were 30 years of age or older. Whole-body MRI of NF1 patients allows assessment of the burden of internal neurofibromas, most of which are not apparent on physical examination. Whole-body imaging of young NF1 patients may allow those at highest risk for developing MPNST to be identified early in life. Close surveillance of these high-risk patients may permit earlier diagnosis and more effective treatment of MPNSTs that develop.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-10525761, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-10675220, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-11283797, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-11865551, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-12011145, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-12403553, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-12403554, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-12403555, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-12660952, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-14517963, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-14722914, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-15257518, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-15289270, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-15520408, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-15523617, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-15776250, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-16033085, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-16043787, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-16404595, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-16442014, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-16786042, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-16818170, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-17215493, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-17362838, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-17613203, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-17613220, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-17649804, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-17885067, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-17932395, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-17978710, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-3082508, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-3128965, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-6405495, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-7851559, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-9126041, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-9207339, http://linkedlifedata.com/resource/pubmed/commentcorrection/18559970-9633723
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1522-8517
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
593-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.
pubmed:affiliation
Department of Maxillofacial Surgery, University Hospital Eppendorf, Hamburg, Germany.
pubmed:publicationType
Journal Article